Allakos ALLK +48% Merger; CervoMed CRVO +36% Phase 2b Data
12 Health Care Stocks Moving In Wednesday's Intraday Session
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Allakos Inc. Buyout
Allakos Officers, Directors, Affiliates Holding About 8.07% of Common Stk Have Signed Support Agreements
Concentra Subsidiary Will Commence Tender Offer by April 15 to Acquire All Outstanding Shrs of Allakos Common Stk >ALLK
Allakos: Board Approved Merger Agreement and Related Transactions >ALLK
Press Release: Allakos Inc. Enters Into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
Express News | Allakos Inc. Enters Into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
Allakos Inc.: Hold Rating Amid Restructuring and Financial Uncertainty
Allakos GAAP EPS of $0.00
Allakos | 10-K: FY2024 Annual Report
Allakos | 8-K: Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
Express News | Allakos Q4 Operating Expenses USD 773 Thousand
Express News | Allakos Q4 Net Income USD 376 Thousand
Press Release: Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
Allakos 4Q EPS 0c >ALLK
Allakos 4Q Net $376,000 >ALLK
Calendar of U.S. Earnings Expected in the Week Ahead
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
Allakos Faces Strategic Uncertainty Following AK006 Phase 1 Trial Failure and Workforce Reduction